Literature DB >> 26318316

Is there any association between primary hyperparathyroidism and ocular changes, such as central corneal thickness, retinal thickness, and intraocular pressure?

Husniye Baser1,2, Neslihan Cuhaci3, Oya Topaloglu3, Fatma Yulek4, Nagihan Ugurlu4, Reyhan Ersoy3, Nurullah Cagil4, Bekir Cakir3.   

Abstract

Ocular changes are commonly encountered in various endocrine disorders. However, only a few studies have reported ocular changes in patients with primary hyperparathyroidism (PHPT). Here, we examined the central corneal thickness (CCT), retinal thickness (RT), and intraocular pressure (IOP), and their relationships with serum intact parathyroid hormone (iPTH), calcium (Ca), and phosphorus (P) levels in patients with PHPT. Thirty-seven eyes of 37 PHPT patients were compared with 43 eyes of 43 age- and sex-matched normal subjects. A detailed ophthalmologic examination, including CCT, RT, and IOP, was performed. CCT and IOP in PHPT patients were significantly higher than controls (p = 0.024 and p = 0.038, respectively). No statistically significant difference was detected in RT between the two groups (p = 0.730). iPTH levels were positively correlated with CCT and IOP (r = 0.304, p = 0.006 and r = 0.249, p = 0.026, respectively). No significant correlation was found between iPTH levels and RT (p > 0.05), and between serum Ca levels, and RT, CCT, and IOP (all, p > 0.05). While there was a negative correlation between serum P levels and CCT (r = -0.264, p = 0.018), no correlation was observed between serum P levels, and RT and IOP (both, p > 0.05). Using multiple regression analyses, iPTH, serum Ca, and serum P levels were found to have no significant associations with CCT, IOP, and RT (all, p > 0.05). There was no significant association between PHPT, and CCT, RT, and IOP. We postulate that the identification of ocular aspects of PHPT is significant, and further studies related to this condition are required.

Entities:  

Keywords:  Central corneal thickness; Intraocular pressure; Primary hyperparathyroidism; Retinal thickness

Mesh:

Substances:

Year:  2015        PMID: 26318316     DOI: 10.1007/s12020-015-0724-5

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  46 in total

Review 1.  Diagnosis and management of primary hyperparathyroidism.

Authors:  Shelley Pallan; Mohammed Omair Rahman; Aliya A Khan
Journal:  BMJ       Date:  2012-03-19

Review 2.  Physiology of local renin-angiotensin systems.

Authors:  Martin Paul; Ali Poyan Mehr; Reinhold Kreutz
Journal:  Physiol Rev       Date:  2006-07       Impact factor: 37.312

Review 3.  Human corneal thickness and its impact on intraocular pressure measures: a review and meta-analysis approach.

Authors:  M J Doughty; M L Zaman
Journal:  Surv Ophthalmol       Date:  2000 Mar-Apr       Impact factor: 6.048

4.  Red eyes in renal failure.

Authors:  G M Berlyne; A B Shaw
Journal:  Lancet       Date:  1967-01-07       Impact factor: 79.321

5.  Assessment of the diurnal variation in central corneal thickness and intraocular pressure for patients with suspected glaucoma.

Authors:  S Shah; C Spedding; R Bhojwani; J Kwartz; D Henson; D McLeod
Journal:  Ophthalmology       Date:  2000-06       Impact factor: 12.079

Review 6.  Rheumatic manifestations of primary hyperparathyroidism and parathyroid hormone therapy.

Authors:  Mishaela R Rubin; Shonni J Silverberg
Journal:  Curr Rheumatol Rep       Date:  2002-04       Impact factor: 4.592

7.  Sclerochoroidal calcification: clinical features, outcomes, and relationship with hypercalcemia and parathyroid adenoma in 179 eyes.

Authors:  Carol L Shields; Murat Hasanreisoglu; Jarin Saktanasate; Patrick W Shields; Ira Seibel; Jerry A Shields
Journal:  Retina       Date:  2015-03       Impact factor: 4.256

8.  Chemical composition of melanosomes, lipofuscin and melanolipofuscin granules of human RPE tissues.

Authors:  Antje Biesemeier; Ulrich Schraermeyer; Oliver Eibl
Journal:  Exp Eye Res       Date:  2011-04-16       Impact factor: 3.467

9.  Corneal thickness as a risk factor for visual field loss in patients with preperimetric glaucomatous optic neuropathy.

Authors:  Felipe A Medeiros; Pamela A Sample; Linda M Zangwill; Christopher Bowd; Makoto Aihara; Robert N Weinreb
Journal:  Am J Ophthalmol       Date:  2003-11       Impact factor: 5.258

10.  Alterations in ocular surface and corneal thickness in relation to metabolic control in patients with chronic renal failure.

Authors:  Zeynep Aktaş; Sengül Ozdek; Umut Asli Dinç; Nalan Akyürek; Veli Atalay; Galip Güz; Berati Hasanreisoglu
Journal:  Nephrology (Carlton)       Date:  2007-08       Impact factor: 2.506

View more
  2 in total

Review 1.  Systemic diseases and the cornea.

Authors:  Ruchi Shah; Cynthia Amador; Kati Tormanen; Sean Ghiam; Mehrnoosh Saghizadeh; Vaithi Arumugaswami; Ashok Kumar; Andrei A Kramerov; Alexander V Ljubimov
Journal:  Exp Eye Res       Date:  2021-01-21       Impact factor: 3.467

2.  Expression profiling suggests the involvement of hormone-related, metabolic, and Wnt signaling pathways in pterygium progression.

Authors:  Jiarui Li; Tianchang Tao; Yingying Yu; Ningda Xu; Wei Du; Mingwei Zhao; Zhengxuan Jiang; Lvzhen Huang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-14       Impact factor: 6.055

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.